Opening Ceremony

• Ponlapat Rojnuckarin (TSH)
• Antonio Almeida (EHA)
• Gianluca Gaidano (EHA)
• Suradej Hongeng (TSH)

Lunch

Lunch Symposium I : Roche Thailand

Chair: Wichean Mongkonsritragoon (Thailand)

•    Advancements in treatment of Diffuse large B-cell lymphoma”
Speaker : Marek Trneny (Czech Republic)

Session 2 : Acute Leukemia

Chairs:  Pimjai Niparuck (Thailand)  |  Natasha Ali (Pakistan)

•    Molecular landscape in elderly AML
Speaker : Lars Bullinger (Germany)
•    Impact of measurable residual disease for precision medicine in AML
Speaker : Sylvie Freeman (United Kingdom)
•    Cellular Therapy in Pediatric Leukemias
Speaker :  Usanarat Anurathapan (Thailand)
•    Panel Discussion
Speaker : All Speakers

Coffee Break | Exhibition

Session 3: Red cell disorders & Bone marrow failure

Chairs:   Abdul Aziz (Bangladesh)  |  Angelina Mirasol (Philippines)

•    Guidelines on Use of NGS in the diagnosis of congenital anemias
Speaker : Noemi Roy (United Kingdom)
•    Fanconi anemia as a paradigm of clonal evolution in a deficient hematopoiesis
Speaker  : Jean Soulier (France)
•    Non-transfusion-dependent thalassemia: An update on complications and management
Speaker : Ali Taher (Lebanon)
•    Panel Discussion
Speaker : All Speakers

Janssen EHA2022 Sponsored Content-Optimizing treatment selection and sequencing for patients with multiple myeloma (MM) a precision medicine approach

Janssen EHA2022 Sponsored Content-Minimal residual disease (MRD): the big question mark in chronic lymphocytic leukemia (CLL)

Janssen EHA2022 Sponsored Content-Immunotherapies: Rising to the challenge of relapsed/refractory multiple myeloma (MM)

Janssen EHA2022 Sponsored Content-Immunotherapy: evolution or revolution in the cure of multiple myeloma